BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 38004483)

  • 1. Esterase-Responsive Polyglycerol-Based Nanogels for Intracellular Drug Delivery in Rare Gastrointestinal Stromal Tumors.
    Schötz S; Griepe AK; Goerisch BB; Kortam S; Vainer YS; Dimde M; Koeppe H; Wedepohl S; Quaas E; Achazi K; Schroeder A; Haag R
    Pharmaceuticals (Basel); 2023 Nov; 16(11):. PubMed ID: 38004483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tunable Polyglycerol-Based Redox-Responsive Nanogels for Efficient Cytochrome C Delivery.
    Schötz S; Reisbeck F; Schmitt AC; Dimde M; Quaas E; Achazi K; Haag R
    Pharmaceutics; 2021 Aug; 13(8):. PubMed ID: 34452237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Avapritinib in the treatment of PDGFRA exon 18 mutated gastrointestinal stromal tumors.
    Smrke A; Gennatas S; Huang P; Jones RL
    Future Oncol; 2020 Aug; 16(22):1639-1646. PubMed ID: 32517495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and functionalization of dendritic polyglycerol-based nanogels: application in T cell activation.
    Reisbeck F; Wedepohl S; Dimde M; Schmitt AC; Dernedde J; Álvaro-Benito M; Freund C; Haag R
    J Mater Chem B; 2021 Dec; 10(1):96-106. PubMed ID: 34881771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Avapritinib in unresectable or metastatic gastrointestinal stromal tumor with PDGFRA exon 18 mutation: safety and efficacy.
    Henriques-Abreu M; Serrano C
    Expert Rev Anticancer Ther; 2021 Oct; 21(10):1081-1088. PubMed ID: 34404327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Boronate cross-linked ATP- and pH-responsive nanogels for intracellular delivery of anticancer drugs.
    Zhang X; Achazi K; Haag R
    Adv Healthc Mater; 2015 Mar; 4(4):585-92. PubMed ID: 25388994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinicopathological features and prognosis of gastrointestinal stromal tumors with
    Shen YY; Li XQ; Yang LX; Fang Y; Nie MM; He ZR; Hou YY; Cao H; Wang M; Shen KT
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Sep; 24(9):804-813. PubMed ID: 34530562
    [No Abstract]   [Full Text] [Related]  

  • 8. Ripretinib for the treatment of advanced gastrointestinal stromal tumor.
    Zalcberg JR
    Therap Adv Gastroenterol; 2021; 14():17562848211008177. PubMed ID: 33948116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multifunctional PVCL nanogels with redox-responsiveness enable enhanced MR imaging and ultrasound-promoted tumor chemotherapy.
    Xu F; Zhu J; Lin L; Zhang C; Sun W; Fan Y; Yin F; van Hest JCM; Wang H; Du L; Shi X
    Theranostics; 2020; 10(10):4349-4358. PubMed ID: 32292499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systematic Screening of Different Polyglycerin-Based Dienophile Macromonomers for Efficient Nanogel Formation through IEDDA Inverse Nanoprecipitation.
    Oehrl A; Schötz S; Haag R
    Macromol Rapid Commun; 2020 Jan; 41(1):e1900510. PubMed ID: 31750985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Redox-Sensitive and Intrinsically Fluorescent Photoclick Hyaluronic Acid Nanogels for Traceable and Targeted Delivery of Cytochrome c to Breast Tumor in Mice.
    Li S; Zhang J; Deng C; Meng F; Yu L; Zhong Z
    ACS Appl Mater Interfaces; 2016 Aug; 8(33):21155-62. PubMed ID: 27509045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Avapritinib in Patients With Advanced Gastrointestinal Stromal Tumors Following at Least Three Prior Lines of Therapy.
    George S; Jones RL; Bauer S; Kang YK; Schöffski P; Eskens F; Mir O; Cassier PA; Serrano C; Tap WD; Trent J; Rutkowski P; Patel S; Chawla SP; Meiri E; Gordon M; Zhou T; Roche M; Heinrich MC; von Mehren M
    Oncologist; 2021 Apr; 26(4):e639-e649. PubMed ID: 33453089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical efficacy comparison of avapritinib with other tyrosine kinase inhibitors in gastrointestinal stromal tumors with PDGFRA D842V mutation: a retrospective analysis of clinical trial and real-world data.
    von Mehren M; Heinrich MC; Shi H; Iannazzo S; Mankoski R; Dimitrijević S; Hoehn G; Chiroli S; George S
    BMC Cancer; 2021 Mar; 21(1):291. PubMed ID: 33740926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinicopathological features and prognosis of gastrointestinal stromal tumor with PDGFRA-D842V mutation].
    Li XQ; Tu L; Wang M; Ma XL; Yang LX; Shen YY; Zhuang C; Zhao WY; Qiu JF; Zhao G; Cao H
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Sep; 23(9):872-879. PubMed ID: 32927512
    [No Abstract]   [Full Text] [Related]  

  • 15. EGFR and CD44 Dual-Targeted Multifunctional Hyaluronic Acid Nanogels Boost Protein Delivery to Ovarian and Breast Cancers In Vitro and In Vivo.
    Chen J; Ouyang J; Chen Q; Deng C; Meng F; Zhang J; Cheng R; Lan Q; Zhong Z
    ACS Appl Mater Interfaces; 2017 Jul; 9(28):24140-24147. PubMed ID: 28675028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclo(RGD)-Decorated Reduction-Responsive Nanogels Mediate Targeted Chemotherapy of Integrin Overexpressing Human Glioblastoma In Vivo.
    Chen W; Zou Y; Zhong Z; Haag R
    Small; 2017 Feb; 13(6):. PubMed ID: 27865044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Charge-conversional and reduction-sensitive poly(vinyl alcohol) nanogels for enhanced cell uptake and efficient intracellular doxorubicin release.
    Chen W; Achazi K; Schade B; Haag R
    J Control Release; 2015 May; 205():15-24. PubMed ID: 25445693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PDGFRA Immunohistochemistry Predicts PDGFRA Mutations in Gastrointestinal Stromal Tumors.
    Papke DJ; Forgó E; Charville GW; Hornick JL
    Am J Surg Pathol; 2022 Jan; 46(1):3-10. PubMed ID: 33859072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biocompatibility and characterization of polyglycerol-based thermoresponsive nanogels designed as novel drug-delivery systems and their intracellular localization in keratinocytes.
    Gerecke C; Edlich A; Giulbudagian M; Schumacher F; Zhang N; Said A; Yealland G; Lohan SB; Neumann F; Meinke MC; Ma N; Calderón M; Hedtrich S; Schäfer-Korting M; Kleuser B
    Nanotoxicology; 2017 Mar; 11(2):267-277. PubMed ID: 28165853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of resistance to imatinib mesylate in gastrointestinal stromal tumors and activity of the PKC412 inhibitor against imatinib-resistant mutants.
    Debiec-Rychter M; Cools J; Dumez H; Sciot R; Stul M; Mentens N; Vranckx H; Wasag B; Prenen H; Roesel J; Hagemeijer A; Van Oosterom A; Marynen P
    Gastroenterology; 2005 Feb; 128(2):270-9. PubMed ID: 15685537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.